Best-selling in Manuals & Resources
Save on Manuals & Resources
- £10.35Trending at £11.01
- £8.95Trending at £9.95
- £17.19Trending at £17.84
- £8.75Trending at £9.14
- £24.93Trending at £25.93
- £11.71Trending at £12.84
- £21.48Trending at £29.18
About this product
- Author(s)Pierfausto Seneci
- PublisherElsevier Science Publishing Co Inc
- Date of Publication09/10/2014
- GenreClinical Medicine: Professional
- Place of PublicationSan Diego
- Country of PublicationUnited States
- ImprintAcademic Press Inc
- Table Of ContentsChapter 1 - Protein misfolding, neurodegeneration and Tau: The main players, or the usual suspects? Chapter 2 - Targeting the protein quality control (PQC) machinery: The neuronal Salvation Army. Chapter 3 - Proteasomal degradation of soluble, misfolded proteins: Throwing out the bath water, but where's the baby? Chapter 4 - Unselective disposal of cellular aggregates: Engulf, devour and digest to recycle. Chapter 5 - Selective disposal of insoluble protein aggregates: Pick, transport and remove to cure. Chapter 6 - Assembly and disassembly of protein aggregates: Unraveling the maze. Conclusion
- Author BiographyDr. Pierfausto Seneci is Associate Professor in the Department of Organic and Industrial Chemistry at the University of Milan. He is currently affiliated with the University of Milan Centre for Interdisciplinary Biomolecular Studies and Industrial Applications (CISI) Centre of Excellence, and is responsible for the Combinatorial Chemistry/High Throughput MedChem Laboratory. He has over 20 years of medicinal chemistry experience working in industry, and held business development positions with GSK, Sanofi, and start-up pharmaceutical companies including Sirenade and NiKem working in drug discovery, neurodegeneration, oncology, and antibacterials. He is author of approximately 80 papers on the topic and several book chapters, including the book Solid-Phase Synthesis and Combinatorial Technologies with Wiley-Interscience in 2000.
This item doesn't belong on this page.
Thanks, we'll look into this.